EP0377016A1 - Verfahren zur trennung und wiedergewinnung von geladenen molekülen - Google Patents
Verfahren zur trennung und wiedergewinnung von geladenen molekülenInfo
- Publication number
- EP0377016A1 EP0377016A1 EP19890906608 EP89906608A EP0377016A1 EP 0377016 A1 EP0377016 A1 EP 0377016A1 EP 19890906608 EP19890906608 EP 19890906608 EP 89906608 A EP89906608 A EP 89906608A EP 0377016 A1 EP0377016 A1 EP 0377016A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polymer
- electrically conductive
- current
- ligand
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000008569 process Effects 0.000 title claims description 34
- 238000000926 separation method Methods 0.000 title claims description 21
- 238000011084 recovery Methods 0.000 title description 5
- 229920000642 polymer Polymers 0.000 claims abstract description 26
- 229920001940 conductive polymer Polymers 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 230000027455 binding Effects 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 18
- 239000003446 ligand Substances 0.000 claims description 15
- 239000011159 matrix material Substances 0.000 claims description 11
- 229920000128 polypyrrole Polymers 0.000 claims description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
- 239000002322 conducting polymer Substances 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 239000004020 conductor Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- -1 diazobenzyloxymethyl Chemical group 0.000 claims description 5
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 102000016942 Elastin Human genes 0.000 claims description 3
- 108010014258 Elastin Proteins 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 229920002549 elastin Polymers 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229920001197 polyacetylene Polymers 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- 239000000020 Nitrocellulose Substances 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229920002684 Sepharose Polymers 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000021466 carotenoid Nutrition 0.000 claims description 2
- 150000001747 carotenoids Chemical class 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 230000005684 electric field Effects 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims description 2
- 229920001220 nitrocellulos Polymers 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920000123 polythiophene Polymers 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 239000000872 buffer Substances 0.000 description 14
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000003181 biological factor Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000002870 angiogenesis inducing agent Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001853 pulsed-field electrophoresis Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
Definitions
- the present invention relates to a selective method for the purification and recovery of charged molecules from mixtures. More particularly, the present invention is concerned with the purification of horticultural factors or biologically active factors on a chromatographic and/or electrophoresis apparatus through the use of electrical current or voltage. The invention also provides an apparatus for performing electrical chromatography.
- volume reduction may not appear relevant at the lab bench, it is essential for production. Process volumes should be reduced as early as possible, using techniques that offer both high capacity and high selectivity. Ion-exchange chromatography is thus a very good first step because of its capacity (approximately 30 mg protein per ml) and relatively low cost. As with other adsorption techniques, ion exchange is relatively independent of feed volume. However, ion exchange chromatography does not provide a high degree of selectivity and much of the active factors remain on the adsorbent. Gel filtration, though a frequent first step at the laboratory scale, is not suitable for handling large volumes. When gel filtration is used to separate molecules of similar molecular weights, sample sizes may range only from 1 percent to 3 percent of the total gel volume.
- a 100-liter feed-stream would require a gel filtration column of 10,000-50,000 liters, whole the same 100-liter stream could possibly be applied to a 20-liter ion-exchange column, depending on the sample concentration and process conditions. If one is separating a large molecule from a small molecule—as in buffer exchange (or "desalting")—the applied sample volume may be up to 30 percent of the total gel volume.
- Affinity chromatography the most selective technique, may be used fairly early in purification. There are drawbacks to using affinity chromatography if the affinity ligand is expensive and the feedstream fouls the media. The bulk of contaminants, such as lipids, should be removed first.
- affinity chromatography must also employ the conventional purification techniques when the substrate is complex.
- Electrophoresis provides an effective method for adsorbing or desorbing bound material. It is very useful for desorbing tightly bound material from affinity adsorbents and is especially useful for desorbing tightly bound substances such as antibodies and hormone-finding proteins. However, electrophoresis is dependent upon the selectiveness of the adsorbent utilized and the fluid medium through which the electrical current is passed.
- the present invention provides an apparatus and a method for the separation and recovery of commercially useful products from a substrate. More particularly, the invention provides a means for the separation of biologically inert and/or biologically active factors from a substrate wherein the biologically active factors may be in the form of cell homogenates of organ tissues,- or microorganisms, of plant material and/or of body liquids.
- a chromatographic column is filled with an electrically conductive polymer and an electrical current sufficient to cause binding is passed through the polymer.
- the substance of interest in a suitable solvent is then eluted by altering the charges on the polymer.
- the amount and type of current used can readily be determined beforehand by preliminary runs.
- alternating current preferably 1-60 herz
- Direct current 0.5 to 5 milliamp ⁇
- fibroblasts lymphocytes
- epithelial cells yeast, reticular endothelial cells, and the like. It is also possible to achieve a desirable separation with these cell types.
- separation is achieved when a biospecific ligand is ionically attached to the chromatographic bed material by means of an electrical current or voltage while retaining a specific binding affinity for a factor of interest.
- the fact is then passed through the column and the factor bound to the ligand.
- the factor alone or together with the ligand to which it is bound may be detached by a change of electrical charge.
- the selection of the ligand for the electrical chromatograph is influenced by two factors. First, the ligand should exhibit specific and reversible binding affinity for the factor to be purified. Second, it should have groups which allow it to covalently attach to the electrically charged matrix without destroying its binding activity.
- the biological factors which can be separated in the process of the present invention may be animal, plant or microorganism.
- the animal factors include those derived from mammalian, avian and amphibian or bacterial, fungal or viral origin. Those of fungal origin include aspergillus and rhizopus.
- Bacterial microorganisms include and are not limited to Bacillus and Clostridium genera.
- the method of the invention is especially useful in the separation and purification of chemical products derived in the cultivation of E. Coli and yeast through biotechnological procedures. That is, not only can the biologically active factors from naturally occurring microorganisms and cells be separated, but also factors from microorganisms and cells which have been modified by genetic engineering techniques, such as transformation, DNA insertions, transduction, fusion and the like.
- the invention is especially useful in the separation of active factors derived from human . diploid cells.
- the invention is adaptable to the separation and purification of all types of biological factors including, for example, the factors derived from mammalian, avian amphibian cells. Factors derived from embryonic, adult or tumor tissues as well as from established cell lines can thus be separated. Examples of typical cells from which the factors may be separated are primary rhesus monkey kidney cells, baby hamster kidney cells, pig kidney cells, mouse embryo fibroblasts, normal human lung embryo fibroblasts, HeLa cells, primary and secondary chick fibroblasts, and various cells transformed with SV-40 polyoma virus. Separation of the charged particles utilizing DC current is usually performed with about 0.5 ⁇ amps to 15 amps. Alternatively the charged particles can be separated with the use of constant current, constant potential, alternating current alone or pulsed with direct current, transversed alone or in combination with direct current or together with electrophoresis.
- DC current is preferred for use in the separation of amino acids, proteins, glycoproteins, yeast, bacteria cells, nucleic acids, sugards, lipids, glycolipids, organelles, chromagens and inorganic charged molecules.
- the cells can be harvested and further treated for the production of desired products by various means.
- human diploid foreskin fibroblasts cultured by the method of this invention for example, see copending application U.S.S.N. 111,360 entitled “Method for Producing Cells” filed October 2, 1987 can be treated for the production of angiogenic factor, plas inogen activator and interfer ⁇ n.
- the angiogenic factor alone can be isolated from the growth medium or from the cells.
- Plasminogen activator can be separated from a serum-free maintenance medium during a period of aging after the cells have reached their maximum density.
- the electrically conductive materials which may be utilized in the present invention are the natural and synthetic polymers including gums which are normally utilized in the cultivation of cells and which are are electrically conductive or have been made electrically conductive by incorporation or intercalation of other polymers or materials.
- the aforementioned article of Qian, et al discloses such materials and how the material can be made electrically conductive.
- One way of preparing conductive polymers is by polymerizing in situ acetylene, pyrrole, and thiophene in a flexible matrix as described by Qian, et al.
- Molecular composites with polyacetylene, polypyrrole, polythiophene, polystyrene, and the like may be prepared with nylon, polyvinyl chloride, polyvinyl alcohol, polyvinyl acetate, polyvinyl butyral, polyethylene glycol, gelatin, collagen, guar gum, elastin, glycoproteins carotenoids, hemins, diazobenzyloxymethyl, nitrocellulose, paper, agarose, sepharose, sephadex, carbohydrate containing substances, and the like.
- the following examples are illustrative of the present invention. It will be apparent to those skilled in the art that many modifications, both of materials and methods, can be made without departing from the spirit and scope of the invention.
- a polysaccharide matrix, cellulose dialysis membrane, is suspended in a solution prepared by dissolving approximately 54 ml of pyrrole in 2000 ml of 0.10 M NaCl. The duration of the suspension (from seconds to days) and the temperature of the solution (from 0° to 20°C.) do not significantly affect the subsequent formation of the conducting polymer film.
- the oxidizing solution is prepared by dissolving 46 g of ammonium persulfate ((NH4) 2 S 2 0 8 ) in 2000 ml of 0.10 M NaCl. The oxidizing solution is then added to the solution containing the monomer and the matrix. The solution changes color from clear to aqua to black.
- the wash process removes excess conducting polymer from the conducting polymer film.
- the resulting material is dried and ground to form a powder. Conductivity was measured and found to be 0.1 to 1 S/cm.
- the polymer powder is suitable for chro atographing animal factors.
- ferric chloride may be used.
- a polysaccharide matrix, cellulose dialysis membrane, is suspended in a solution prepared by dissolving approximately 200 ml of aniline in 3000 ml of 1.0 M HC1.
- the oxidizing solution is prepared by dissolving 111 g of ammonium persulfate ((NH 4 ) 2 S2 ⁇ 8 ) in 2000 ml of 1.0 M HC1.
- the oxidizing solution is then added to the solution containing the monomer and the matrix. Over a period of several seconds (less than 1 minute) , the solution changes color from clear to aqua to green.
- the cellulose matrix is removed and washed with copious quantities of 1.0 M HcL.
- the wash process removes excess conducting polymer from the conducting polymer film.
- the resulting material is allowed to dry and ground to a powder.
- the conductivity is measured and found to be 0.1 to 1 S/cm. This polymer has been used for separating factors derived from fungal microorganisms.
- the solution was then filtered through glass wool.
- the dark filtrate contained polypyrrole polyvinyl alcohol (grafted) polymer in solution.
- the filtrate was then poured slowly into 5 liters of acetonitrile and left undisturbed for 1-2 hours.
- the casting of polymer on the organic solvent resulted in thin film of the polymer (black in color) .
- the solvent was discarded and the black film was washed three times with 1 liter acetonitrile, dried and ground.
- conductive polymers comprising polystyrene-pyrrole, polyvinylbutyral-pyrrole, polyethylene-pyrrole and polypropylene-pyrrole.
- microgranular cellulose powder (Whatman, cc41, cat #4061 - 050) was suspended in 2 liters of monomer solution(108 ml of pyrrole/0.1 M NaCl) overnight at 4 C C. The suspension of cellulose powder was then stirred gently for 2 hours, after which 2 liters of 0.2 M ammonium persulfate in 0.1 M NaCl was added in a dropwise manner, with stirring. Stirring was continued for 1 hour, then the powder was washed three times with saline solution and then several times with water, till the supernatant was free of chloride ions. The aqueous suspension of cellulose was filtered and dried. The resistance of the cellulose was measured by two pin probes attached to a multimeter. The average resistance of the material was 0.1 to 0.7 k ohms, when the probes were placed about 1 to 2 cms apart.
- Dispersion polymerization reactions were carried out in 5 1 flasks. Initially x g of PVA, plus 88.3 g (0.033 moles) of FeCl 3 • 6H 2 was dissolved in 1 of water. To this solution was added 10 ml (0.014 moles) of purified pyrrole monomer, and the mixture was stirred (magnetically) at 20 ⁇ C for 18-24 h. It was shown, in all cases, that greater than 95% conversion of monomer was achieved within this time. Within a few seconds of adding the pyrrole to the reaction mixture, the color changed from orange to brown-black, indicative of the onset of polymerization, but not precipitate was formed.
- the dispersions formed were centrifuged at 15,000 rpm for about 1 h. This lead to a black sediment and a pale green, but transparent supernatant. Indeed, it was subsequently shown by visible absorption spectroscopy that the supernatant contained no polypyrrole. The sediment could be readily redispersed by shaking in pure water. The dispersions formed in this way showed no tendency to aggregate on standing. The aqueous dispersion were freeze-dried to yield a fine, black powder.
- the current was changed to 3 milliamps and the column was eluted with buffer (30 ml) and the fractions were saved (II) .
- the current was changed to 1.5 milliamps and the column was eluted with buffer (30 ml) and the fractions saved (III) .
- the separation can also be performed with alternating current utilizing 0.5 ⁇ A - 10 A (1 - 60 Hz) .
- alternating current utilizing 0.5 ⁇ A - 10 A (1 - 60 Hz) .
- there may be utilized a constant potential or a potential gradient down the column.
- EXAMPLE 8 The procedure of Example 7 was followed except that a constant potential of 3 V is applied to the column. The mixture of yeast is added to the column and eluted with buffer and the first fraction saved. The voltage was changed to 1.5 V and the column was further eluted with buffer and these fractions were saved.
- the voltage was changed to 0.1 V and the remainder of the column was eluted.
- EXAMPLE 9 A chromatographic column is filled with electrically conductive polypyrrole-agarose. Separate electrode sets were positioned to provide an angle of 115° between the fields. A programmed regulator was utilized for switching of fields so as to provide pulsed electrical fields alternating between AC and DC current. 100 volt potential was applied to each field and pulsed alternately every two seconds. The AC current applied was 20 Hz.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19501988A | 1988-05-17 | 1988-05-17 | |
| US195019 | 1988-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0377016A1 true EP0377016A1 (de) | 1990-07-11 |
Family
ID=22719747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19890906608 Withdrawn EP0377016A1 (de) | 1988-05-17 | 1989-05-17 | Verfahren zur trennung und wiedergewinnung von geladenen molekülen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0377016A1 (de) |
| WO (1) | WO1989011648A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016331A1 (en) * | 1994-11-18 | 1996-05-30 | Aromascan Plc | Method for depositing a conducting polymer into a tube by vapour phase chemical oxidation and its use as chromatography column |
| WO1998020043A1 (en) | 1996-11-08 | 1998-05-14 | Morphogenesis, Inc. | Materials and procedures for the purification of cells |
| US6428666B1 (en) * | 1999-02-22 | 2002-08-06 | Sandia National Laboratories | Electrokinetic concentration of charged molecules |
| DE60029794T2 (de) | 1999-04-23 | 2007-10-18 | Nexttec Gmbh | Verwendung von mit polymer beschichtetem sorptionsmittelkomposit zur trennung, reinigung, entsalzung und konzentrierung von biopolymeren |
| EP2223307B1 (de) | 2007-11-27 | 2018-09-19 | Uppsala Universitets Projekt AB | Verbundmaterialien mit einem intrinsisch leitenden polymer und verfahren und einrichtungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3346813A (en) * | 1964-06-26 | 1967-10-10 | Litton Systems Inc | Converter using spin resonant material |
| US3640813A (en) * | 1969-06-09 | 1972-02-08 | Samuel T Nerenberg | Adapter for a macromolecule separation device |
| US4238327A (en) * | 1979-06-25 | 1980-12-09 | Liburdy Robert P | Electric resonance chromatography |
-
1989
- 1989-05-17 EP EP19890906608 patent/EP0377016A1/de not_active Withdrawn
- 1989-05-17 WO PCT/US1989/002144 patent/WO1989011648A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8911648A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1989011648A1 (en) | 1989-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0282042B1 (de) | Neue Fusionsproteine und deren Reinigung | |
| Tsai et al. | Studies on a mammalian cell protein (P8) with affinity for DNA in vitro | |
| Fei et al. | Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras | |
| Buckmire et al. | Studies on the cell wall of Spirillum serpens. II. Chemical characterization of the outer structured layer | |
| JPH06102034B2 (ja) | タンパク質の生産方法 | |
| Moore et al. | Possible origin of a minor virus specific protein (A1) in Qβ particles | |
| CN112063643B (zh) | 一种用于检测细菌中膜蛋白相互作用的表达载体及方法 | |
| JPH087187B2 (ja) | 低電気浸透アガロース | |
| CN111448315B (zh) | 一种Cas蛋白体系分离DNA的方法 | |
| JPH07102000A (ja) | 疎水性ポリペプチド、タンパク質又はペプチドの製造方 法 | |
| EP0377016A1 (de) | Verfahren zur trennung und wiedergewinnung von geladenen molekülen | |
| JPH0440989B2 (de) | ||
| RU2081122C1 (ru) | Способ выделения и очистки инсулина или его биотехнологических предшественников | |
| Carreira et al. | Construction and application of a modified “gene machine”: A circular concentrating preparative gel electrophoresis device employing discontinuous elution | |
| US6406892B1 (en) | Acetate-free purification of plasmid DNA on hydroxyapatite | |
| JP3359370B2 (ja) | 分離回収用電気泳動ゲルおよびそれを用いた分離回収法 | |
| CN111349623A (zh) | 9°n dna聚合酶突变体 | |
| CN110407909B (zh) | 一种多肽序列及其自组装材料的制备方法及应用 | |
| JPH03501167A (ja) | 荷電分子の分離及び回収のための方法 | |
| CN121496045B (zh) | 一种cel-iii蛋白及其突变体在纳米孔检测中的应用 | |
| Weideli et al. | A New Method for the Purification of DNA‐Binding Proteins with Sequence Specificity | |
| AU716006B2 (en) | Process of recovering and purifying protein | |
| CN109913435B (zh) | 一种羧肽酶及其编码基因、重组载体、重组菌及应用 | |
| CN119735657A (zh) | 一种具有优良吸附水体微塑料能力的CsgA蛋白重组体及其应用 | |
| Fogel | Isolation and Analysis of Single Ribosomal Proteins From Escherichia Coli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19900215 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 18W | Application withdrawn |
Withdrawal date: 19921117 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| R18W | Application withdrawn (corrected) |
Effective date: 19921117 |